Index of reports
> Life Threatening Events (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sumatriptan life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Sumatriptan side effects in 68 year old female
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient: 68 year old female, weighing 70.3 kg (154.7 pounds)
Reactions: Product Substitution Issue, Migraine, Drug Ineffective
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Sumatriptan
Topiramate
Possible Sumatriptan side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-14
Patient: male
Reactions: Cytogenetic Abnormality, Dysmorphism, Maternal Drugs Affecting Foetus, Glaucoma, Pneumonia Aspiration, Micrognathia, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Developmental Delay, Respiratory Disorder Neonatal, Laryngomalacia, Gastrooesophageal Reflux Disease, Myopia, Ear Infection, Torticollis, Deafness Congenital, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Olopatadine Hydrochloride
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Nitrofurantoin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Cetirizine
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Azithromycin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Topiramate
Dosage: 50 mg (25 mg, 2 in 1 d), transplacental
Indication: Migraine
Start date: 2010-03-15
End date: 2010-04-15
Amoxicillin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Ibuprofen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Hydrocodone Bitartrate and Acetaminophen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Sumatriptan
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Fluticasone Propionate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Cyclobenzaprine
Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
Indication: Sciatic Nerve Injury
Naproxen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Prenatal Vitamins (Prenatal Viotamins / 01549301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Possible Sumatriptan side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-04
Patient: male
Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Cytogenetic Abnormality, Glaucoma, Pierre Robin Syndrome, Deafness, Micrognathia, Body Dysmorphic Disorder, Cleft Palate, Caesarean Section, Developmental Delay, Cough, Dyspnoea, Chest Discomfort, Myopia, Craniosynostosis, Bronchial Hyperreactivity
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclobenzaprine
Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
Indication: Sciatic Nerve Injury
Amoxicillin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Topiramate
Dosage: 50;100;1w mg (25 mg, 2 in 1 d), transplacental
Indication: Migraine
Naproxen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Sumatriptan
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Nitrofurantoin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Hydrocodone Bitartrate and Acetaminophen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Prenatal Vitamins (Prenatal Vitamins (01549301)
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Fluticasone Propionate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Azithromycin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Ibuprofen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Cetirizine
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Olopatadine Hydrochloride
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Possible Sumatriptan side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-01-23
Patient: 61 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Peripheral Coldness, Antipsychotic Drug Level Increased, Rhabdomyolysis, Contusion, Tachycardia, Mental Status Changes, Pyrexia, Serotonin Syndrome, Muscle Rigidity, Fall, Haemodynamic Instability, Malaise, Aspiration, Cyanosis, Abdominal Distension, Tachypnoea, Electrolyte Imbalance, Neuroleptic Malignant Syndrome, Hypotension, General Physical Health Deterioration, Livedo Reticularis, Antidepressant Drug Level Increased, Apallic Syndrome, Anxiety, Renal Failure, Respiratory Failure, Breath Sounds Abnormal, Depressed Level of Consciousness, Septic Shock, Leukocytosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Fluconazole
Dosage: 150 mg;
Trimethoprim
Dosage: 160 mg; qd
Haloperidol Lactate
Dosage: 20 mg; hs
Mometasone Furoate
Dosage: 2 sprays; bid; inh
Alendronate Sodium
Dosage: 70 mg; qw
Celecoxib
Dosage: 200 mg; bid
Furosemide
Dosage: 40 mg; qd
Cyclobenzaprine
Dosage: 10 mg; prn
Prednisone TAB
Dosage: 7.5 mg; qd
Hydroxyzine
Dosage: 25 mg; bid
Loperamide
Dosage: 2 mg; prn
Hydroxychloroquine Sulfate
Dosage: 200 mg; bid
Lorazepam
Dosage: 2 mg; hs;
Omeprazole
Dosage: 20 mg; bid
Risperidone
Dosage: 2 mg; qam
Estrogens Conjugated
Dosage: 1.3 mg; qd
Desipramine HCL
Dosage: 25 mg; bid
Quetiapine Fumarate
Dosage: 1800 mgl qd
Start date: 2009-09-01
End date: 2009-09-01
Trazodone HCL
Dosage: 200 mg; qhs
Venlafaxine
Dosage: 75 mg; bid
Budesonide
Dosage: 200 mcg; qd; inh
Atorvastatin Calcium
Dosage: 10 mg; qd
Levothyroxine Sodium
Dosage: 50 mcg; qd
Sumatriptan
Dosage: 50 mg; prn
Sulfamethoxazole
Dosage: 800 mg; qd
|